ArticleCancers2022

Risk Stratification Using a Novel Nomogram for 2190 EGFR-Mutant NSCLC Patients Receiving the First or Second Generation EGFR-TKI.

John Wen-Cheng Chang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.